Previous close | 8.95 |
Open | 8.83 |
Bid | 8.72 x 40000 |
Ask | 8.75 x 40000 |
Day's range | 8.50 - 9.00 |
52-week range | 3.42 - 14.50 |
Volume | |
Avg. volume | 553,657 |
Market cap | 1.601B |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.26 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 17.70 |
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Brooksville, Florida, marking the Company's 200th dispensary in the United States.
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has reached an agreement resolving the active litigation.
A change in classification is moving closer to reality. Multistate weed sellers would be the immediate beneficiaries.